You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,197,853


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,197,853
Title:Combination therapy
Abstract: Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or a prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.
Inventor(s): Kopczynski; Casey (Chapel Hill, NC), Lin; Cheng-Wen (Raleigh, NC), Sturdivant; Jill Marie (Chapel Hill, NC), deLong; Mitchell A. (Chapel Hill, NC)
Assignee: Aerie Pharmaceuticals, Inc. (Bedminster, NJ)
Application Number:17/238,554
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,197,853: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the details of United States Patent 11,197,853, exploring its claims, the technology it covers, and the broader patent landscape it inhabits.

Patent Overview

United States Patent 11,197,853, hereafter referred to as the '853 patent, is a document that outlines specific inventions and innovations. To analyze this patent, one must first identify the key elements such as the inventors, the assignees, the filing and issue dates, and the technological field it pertains to.

Claims Analysis

Claim Structure

The claims section of a patent is the most critical part, as it defines the scope of the invention. Claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Types

  • Independent Claims: These claims define the invention broadly and are not dependent on other claims. For the '853 patent, identifying the independent claims will help in understanding the core of the invention.
  • Dependent Claims: These claims build upon the independent claims and provide additional limitations. They often detail specific embodiments or variations of the invention.

Claim Interpretation

Interpreting the claims involves understanding the language and the specific elements described. This can be complex, as claim language is often precise and technical. For instance, in patent litigation, courts may need to construe disputed claim terms to determine the scope of the invention, as seen in cases like Contour IP Holding LLC v. GoPro, Inc.[2].

Technological Coverage

Invention Description

The '853 patent, as indicated in the litigation documents, is directed to specific methods and compositions, such as pharmaceutical compositions containing netarsudil and methods of treating eye diseases like glaucoma and ocular hypertension[5].

Prior Art and Novelty

To understand the value and uniqueness of the '853 patent, it is essential to consider the prior art and how the invention improves upon existing technologies. This involves analyzing the "focus of the claimed advance over the prior art," a key consideration in patent eligibility under the Alice test[2].

Patent Landscape

Related Patents and Applications

The '853 patent is part of a larger family of patents, including continuation and divisional applications that rely on the same provisional application. For example, it is related to other patents such as the '844 and '081 patents, which also pertain to similar pharmaceutical compositions and methods[5].

Competitor Analysis

Understanding the patent landscape involves identifying competitors and their patent portfolios. This can be done through patent analytics, which helps in tracking patents by claims and scope concepts, and identifying gaps or opportunities in the intellectual property coverage[3].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

A Claim Coverage Matrix can be used to categorize patents by claims and overarching scope concepts. This tool is particularly useful for large patent portfolios, as it helps in filtering, searching, and analyzing large numbers of patent claims concurrently[3].

Interactive Claim Charts

Tools like ClaimScape® software generate interactive claim charts that can be reviewed by technical experts to determine the applicability of specific scope concepts to target products or methods. These charts help in identifying gaps in current coverage and highlighting future design opportunities[3].

Valuation of the Patent

Valuation Methods

The value of a patent like the '853 patent can be determined using several methods:

  • Cost Approach: This involves the cost of developing the patent.
  • Income Approach: This looks at the future benefits provided by the patent, such as income or savings.
  • Market Approach: This determines the value based on what a willing buyer would pay for a similar asset[4].

Market and Financial Impact

The financial impact of the '853 patent can be significant, especially given its application in treating serious eye diseases. The market value can be substantial, as seen in the asking prices and sales data for similar pharmaceutical patents[4].

Litigation and Enforcement

Patent Infringement

The '853 patent, like many others, can be subject to litigation if other entities are found to infringe upon its claims. Litigation documents show that the patent holder may induce infringement claims against other parties, highlighting the importance of robust enforcement strategies[5].

Court Decisions and Precedents

Court decisions, such as those under the Alice test, play a crucial role in determining the validity and scope of patent claims. Understanding these precedents is essential for navigating patent litigation and ensuring the enforceability of the patent[2].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the invention.
  • Technological Coverage: The '853 patent covers specific pharmaceutical compositions and methods, improving upon prior art.
  • Patent Landscape: The patent is part of a larger family of related patents and applications.
  • Patent Analytics: Tools like Claim Coverage Matrix and interactive claim charts are essential for managing large patent portfolios.
  • Valuation: The patent's value can be determined using cost, income, and market approaches.
  • Litigation and Enforcement: Robust enforcement strategies and understanding court precedents are vital for protecting the patent.

FAQs

Q: What is the primary focus of the '853 patent?

A: The '853 patent is primarily focused on pharmaceutical compositions containing netarsudil and methods of treating eye diseases such as glaucoma and ocular hypertension.

Q: How do you determine the scope of a patent claim?

A: The scope of a patent claim is determined by interpreting the language of the claims, including both independent and dependent claims, and understanding the specific elements described.

Q: What is the significance of patent analytics in managing a patent portfolio?

A: Patent analytics helps in tracking patents by claims and scope concepts, identifying gaps or opportunities in intellectual property coverage, and providing tools like Claim Coverage Matrix and interactive claim charts.

Q: How is the value of a patent determined?

A: The value of a patent can be determined using the cost approach (development cost), income approach (future benefits), and market approach (what a willing buyer would pay).

Q: Why is understanding court precedents important in patent litigation?

A: Understanding court precedents, such as the Alice test, is crucial for determining the validity and scope of patent claims and ensuring the enforceability of the patent.

Sources

  1. USPTO Search for Patents: https://www.uspto.gov/patents/search
  2. CONTOUR IP HOLDING LLC v. GOPRO, INC.: https://cafc.uscourts.gov/opinions-orders/22-1654.OPINION.9-9-2024_2381170.pdf
  3. Patent Analytics | Intellectual Property Law: https://www.slwip.com/services/patent-analytics/
  4. The Value of a Patent: https://perpetualmotionpatents.com/the-value-of-a-patent/
  5. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT: https://insight.rpxcorp.com/litigation_documents/14657768

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,197,853

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alcon Labs Inc ROCKLATAN latanoprost; netarsudil dimesylate SOLUTION/DROPS;OPHTHALMIC 208259-001 Mar 12, 2019 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,197,853

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3461484 ⤷  Subscribe 301101 Netherlands ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe 2021C/515 Belgium ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe 132021000000068 Italy ⤷  Subscribe
European Patent Office 3461484 ⤷  Subscribe 122021000036 Germany ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.